Advertisement

Role of growth factors and cytokines in diabetic foot ulcer healing: A detailed review

  • Mohammad ZubairEmail author
  • Jamal Ahmad
Article
  • 205 Downloads

Abstract

The aim of the review is to examine the role of growth factors and cytokines in the management of Diabetic Foot Ulcers, such as platelet derived growth factor (PDGF), vascular endothelial growth factor (VEGF), fibroblast growth factor (FGF) and Insulin like growth factor (IGF). Taking this a step further, the role of Hypoxia-inducible factors (HIFs), Transforming growth factor beta 1 (TGF-β-1) and other growth factors have also been examined, with regard to the treatment of diabetic foot ulcers. The roles of these above-mentioned growth cytokines have been analyzed by studying various scholastic articles. The complete process of wound healing is implemented and regulated by numerous cytokines and human growth factors. The findings of the study indicate that wound healing of diabetic foot ulcers is a complex and extremely challenging biological and molecular process that involves coordinated efforts of multiple cell types. The therapeutic effects of various growth factors in the clinical management of wounds are chronic venous ulcers, pressure ulcers, and diabetic foot ulcers. It has been concluded that altercations of various cytokines are found in patients enduring diabetic foot ulcers. In a similar way, changes in the level of cytokines are also found in patients suffering from other diabetic complications such as diabetic nephropathy, retinopathy, and neuropathy. Subsequently, the diabetic wound healing process can be accelerated by regulating the levels of the cytokines.

Keywords

Cytokines Diabetic ulcers Growth factors Molecular process Wound healing Mechanism Vascular endothelial growth factor Insulin 

Notes

Acknowledgments

The author is very thankful to all the associated personnel in any reference that contributed in/for the purpose of this research.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Research involving human participants and/or animals

This article does not contain any studies with human participants or animals performed by any of the authors.

Informed consent

Not applicable.

References

  1. 1.
    American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2007;30:S4–S41.CrossRefGoogle Scholar
  2. 2.
    World Health Organization. Accessible at http://www.who.int/diabetes/en/, retrieved on 7 Nov 2018.
  3. 3.
    Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271–81.CrossRefGoogle Scholar
  4. 4.
    Tuomilehto J, Lindström J, Eriksson JG. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.CrossRefGoogle Scholar
  5. 5.
    Pallela SR, Narahari P. A study to find the causes of diabetic foot infections in a selected community. International Surgery Journal. 2017;4(7):2153–56.  https://doi.org/10.18203/2349-2902.isj20172576.
  6. 6.
    American Diabetic Association. (2018). Accessible at: http://www.diabetes.org/diabetes-basics/statistics/. Retrieved on 11 Nov 2018.
  7. 7.
    Park JW, Hwang SR, Yoon IS. Advanced growth factor delivery systems in wound management and skin regeneration. Molecules. 2017;22(8):1259.CrossRefGoogle Scholar
  8. 8.
    Vlassara H, Uribarri J. Advanced glycation end products (AGE) and diabetes. Cause, effect, or both. Curr Diab Rep. 2014;14:453.  https://doi.org/10.1007/s11892-013-0453-1.CrossRefGoogle Scholar
  9. 9.
    Omanakuttan A, Nambiar J, Harris RM, Bose C, Pandurangan N, Varghese RK, et al. Anacardic acid inhibits the catalytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9. Molecular Pharmacology. 2012: Mol-112.  https://doi.org/10.1124/mol.112.079020.
  10. 10.
    Rupert P. Human acellular dermal wound matrix for complex diabetic wounds. J Wound Care. 2016;25:S17–21.  https://doi.org/10.12968/jowc.2016.25.sup4.s17.CrossRefGoogle Scholar
  11. 11.
    Crafts TD, Jensen AR, Blocher-Smith EC, Markel TA. Vascular endothelial growth factor: therapeutic possibilities and challenges for the treatment of ischemia. Cytokine. 2015;71:385–93.  https://doi.org/10.1016/j.cyto.2014.08.005.CrossRefGoogle Scholar
  12. 12.
    Barrientos S, Brem H, Stojadinovic O, Tomic-Canic M. Clinical application of growth factors and cytokines in wound healing. Wound Repair Regen. 2014;22:569–78.  https://doi.org/10.1111/j.1524-475x.2008.00410.x.CrossRefGoogle Scholar
  13. 13.
    Gowda S, Weinstein DA, Blalock TD. Topical application of recombinant platelet-derived growth factor increases the rate of healing and the level of proteins that regulate this response. Int Wound J. 2015;12:564–71.  https://doi.org/10.1111/iwj.12165.CrossRefGoogle Scholar
  14. 14.
    Heldin C-H, Rönnstrand L. The platelet-derived growth factor receptor. In: Moudgil VK, editor. Receptor phosphorylation. Boca Raton: CRC Press; 1988. p. 149–62.Google Scholar
  15. 15.
    Kolumam G, Wu X, Lee WP. IL-22R ligands IL-20, IL-22, and IL-24 promote wound healing in diabetic db/db mice. PLoS One. 2017;12:e0170639.  https://doi.org/10.1371/journal.pone.0170639.CrossRefGoogle Scholar
  16. 16.
    Gardner JC, Wu H, Noel JG. Keratinocyte growth factor supports pulmonary innate immune defense through the maintenance of alveolar antimicrobial protein levels and macrophage function. Am J Phys Lung Cell Mol Phys. 2016;310:L868–79.  https://doi.org/10.1152/ajplung.00363.2015.Google Scholar
  17. 17.
    Bao P, Kodra A, Tomic-Canic M, Golinko MS, Ehrlich HP, Brem H. The role of vascular endothelial growth factor in wound healing. J Surg Res. 2009;153:347–58.  https://doi.org/10.1016/j.jss.2008.04.023.CrossRefGoogle Scholar
  18. 18.
    Andersen LP, Holck S, Janulaityte-Günther D. Gastric inflammatory markers and interleukins in patients with functional dyspepsia, with and without helicobacter pylori infection. FEMS Immunol Med Microbiol. 2005;44:233–8.  https://doi.org/10.1016/j.femsim.2004.10.022.CrossRefGoogle Scholar
  19. 19.
    Avitabile OT, Madonna S. Interleukin-22 promotes wound repair in diabetes by improving keratinocyte pro-healing functions. J Invest Dermatol. 2015;135:2862–70.  https://doi.org/10.1038/jid.2015.278.CrossRefGoogle Scholar
  20. 20.
    Kolumam G, Wu X, Lee WP, Hackney JA, Zavala-Solorio J, Gandham V, et al. IL-22R ligands IL-20, IL-22, and IL-24 promote wound healing in diabetic db/db mice. PLoS One. 2017;12(1):e0170639.CrossRefGoogle Scholar
  21. 21.
    Braun AC. Bioresponsive delivery of anticatabolic and anabolic agents for muscle regeneration using bioinspired strategies. Available at https://opus.bibliothek.uni-wuerzburg.de/opus4-wuerzburg/frontdoor/deliver/index/docId/16904/file/Braun_Alexandra_Bioresponsive_delivery.pdf
  22. 22.
    Costales J, Kolevzon A. The therapeutic potential of insulin-like growth factor-1 in central nervous system disorders. Neurosci Biobehav Rev. 2016;63:207–22.CrossRefGoogle Scholar
  23. 23.
    Clemmons DR. Role of IGF binding proteins in regulating metabolism. Trends Endocrinol Metab. 2016;27:375–91.  https://doi.org/10.1016/j.tem.2016.03.019.CrossRefGoogle Scholar
  24. 24.
    Boucher J, Kleinridders A, Kahn CR. Insulin receptor signaling in normal and insulin-resistant states. Cold Spring Harb Perspect Biol. 2014;6(1):a009191.CrossRefGoogle Scholar
  25. 25.
    Mason RM, Wahab NA. Extracellular matrix metabolism in diabetic nephropathy. J Am Soc Nephrol. 2003;14(5):1358–73.CrossRefGoogle Scholar
  26. 26.
    Herder C, Brunner EJ, Rathmann W. Elevated levels of the anti-inflammatory interleukin-1 receptor antagonist precede the onset of type 2 diabetes. The Whitehall II study. Diabetes Care. 2009;32:421–3.  https://doi.org/10.2337/dc08-1161.CrossRefGoogle Scholar
  27. 27.
    El Gazaerly H, Elbardisey DM, Eltokhy HM, Teaama D. Effect of transforming growth factor Beta 1 on wound healing in induced diabetic rats. Int J Health Sci. 2013;7(2):160–72.CrossRefGoogle Scholar
  28. 28.
    Chen S, Feng B, Thomas AA, Chakrabarti S. miR-146a regulates glucose induced upregulation of inflammatory cytokines extracellular matrix proteins in the retina and kidney in diabetes. PLoS One. 2017;12(3):e0173918.CrossRefGoogle Scholar
  29. 29.
    Li Y, Zhang Y, Li X, Shi L, Tao W, Shi L, et al. Association study of polymorphisms in miRNAs with T2DM in a Chinese population. Int J Med Sci. 2015;12(11):875–80.CrossRefGoogle Scholar
  30. 30.
    Xu J, Wu W, Zhang L. The role of microRNA-146a in the pathogenesis of the diabetic wound-healing impairment: correction with mesenchymal stem cell treatment. Diabetes. 2012;61:2906–12.  https://doi.org/10.2337/db12-0145.CrossRefGoogle Scholar
  31. 31.
    Mirza RE, Fang MM, Ennis WJ, Koh TJ. Blocking interleukin-1β induces a healing-associated wound macrophage phenotype and improves healing in type 2 diabetes. Diabetes. 2013;62(7):2579–87.  https://doi.org/10.2337/db12-1450.CrossRefGoogle Scholar
  32. 32.
    Robson MC, Payne WG. Growth factor therapy to aid wound healing. Basic and Clinical Dermatology. 2005;33:491.Google Scholar
  33. 33.
    Arfianti E, Barn V, Pok S, Larter CZ, Teoh NC, Farrell. Diabetes augments obesity in accelerating liver tumor development: role of oxidative stress-induced JNK signaling and DNA damage response. J Hepatol. 2017;66:S78–9.  https://doi.org/10.1016/s0168-8278(17)30420-8.CrossRefGoogle Scholar
  34. 34.
    Botusan IR, Sunkari VG, Savu O. Stabilization of HIF-1α is critical to improve wound healing in diabetic mice. Proc Natl Acad Sci. 2008;105:19426–31.  https://doi.org/10.1073/pnas.0805230105.CrossRefGoogle Scholar
  35. 35.
    Mueller CG, Hess E. Emerging functions of RANKL in lymphoid tissues. Front Immunol. 2012;3:261.  https://doi.org/10.3389/fimmu.2012.00261.CrossRefGoogle Scholar
  36. 36.
    Lampropoulou IT, Stangou M, Papagianni A, Didangelos T, Iliadis F, Efstratiadis G. TNF-α and microalbuminuria in patients with type 2 diabetes mellitus. J Diabetes Res. 2014;2014:1–7.CrossRefGoogle Scholar
  37. 37.
    Sugimoto M, Furuta T, Shirai N. Different effects of polymorphisms of tumor necrosis factor-alpha and interleukin-1 beta on development of peptic ulcer and gastric cancer. J Gastroenterol Hepatol. 2007;22:51–9.  https://doi.org/10.1111/j.1440-1746.2006.04442.x.CrossRefGoogle Scholar
  38. 38.
    Liu L, Chen B, Zhang X, Tan L, Wang DW. Increased Cathepsin D correlates with clinical parameters in newly diagnosed type 2 diabetes. Dis Markers. 2017;2017:1–6.Google Scholar
  39. 39.
    Nowak C, Sundström J, Gustafsson S. Protein biomarkers for insulin resistance and type 2 diabetes risk in two large community cohorts. Diabetes. 2016;65:276–84.Google Scholar
  40. 40.
    Necchi V, Sommi P, Vanoli A, Fiocca R, Ricci V, Solcia E. Natural history of helicobacter pylori VacA toxin in human gastric epithelium in vivo. Vacuoles and beyond. Sci Rep. 2017;7(1):14526.  https://doi.org/10.1038/s41598-017-15204-z.CrossRefGoogle Scholar
  41. 41.
    Ayuk SM, Abrahamse H, Houreld NN. The role of matrix metalloproteinases in diabetic wound healing in relation to photobiomodulation. J Diabetes Res. 2016;2016:1–9.CrossRefGoogle Scholar
  42. 42.
    Serra R, Gallelli L, Grande R. Hemorrhoids and matrix metalloproteinases: a multicenter study on the predictive role of biomarkers. Surgery. 2016;159:487–94.  https://doi.org/10.1016/j.surg.2015.07.003.CrossRefGoogle Scholar
  43. 43.
    Singh K, Agrawal NK, Gupta SK, Mohan G, Chaturvedi S, Singh K. Decreased expression of heat shock proteins may lead to compromised wound healing in type 2 diabetes mellitus patients. J Diabetes Complicat. 2015;29:578–88.  https://doi.org/10.1016/j.jdiacomp.2015.01.007.CrossRefGoogle Scholar
  44. 44.
    Gruden G, Bruno G, Chaturvedi N. Prospective complications study group. Serum heat shock protein 27 and diabetes complications in the EURODIAB prospective complications study. A novel circulating marker for diabetic neuropathy. Diabetes. 2008;57:1966–70.  https://doi.org/10.2337/db08-0009.CrossRefGoogle Scholar
  45. 45.
    Nakhjavani M, Morteza A, Khajeali L. Increased serum HSP70 levels are associated with the duration of diabetes. Cell Stress Chaperones. 2010;15:959–64.  https://doi.org/10.1007/s12192-010-0204-z.CrossRefGoogle Scholar
  46. 46.
    Zubair M, Ahmad J. Plasma heat shock proteins (HSPs) 70 and 47 levels in diabetic foot and its possible correlation with clinical variables in a north Indian tertiary care hospital. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 2015;9:237–43.  https://doi.org/10.1016/j.dsx.2015.02.015.CrossRefGoogle Scholar
  47. 47.
    Tsukimi Y, Nakai H, Itoh S, Amagase K, Okabe S. Involvement of heat shock proteins in the healing of acetic acid-induced gastric ulcers in rats. J Physiol Pharmacol. 2001;52:3.  https://doi.org/10.1007/978-94-011-5390-4_28.Google Scholar
  48. 48.
    Dreifke MB, Jayasuriya AA, Jayasuriya AC. Current wound healing procedures and potential care. Mater Sci Eng C. 2015;48:651–62.  https://doi.org/10.1016/j.msec.2014.12.068.CrossRefGoogle Scholar
  49. 49.
    Velnar T, Bailey T, Smrkolj V. The wound healing process: an overview of the cellular and molecular mechanisms. J Int Med Res. 2009;37:1528–42.  https://doi.org/10.1177/147323000903700531.CrossRefGoogle Scholar
  50. 50.
    Thiruvoth FM, Mohapatra DP, Sivakumar DK, Chittoria RK, Nandhagopal V. Current concepts in the physiology of adult wound healing. Plast Aesthet Res. 2015;2:250–6.  https://doi.org/10.4103/2347-9264.158851.CrossRefGoogle Scholar
  51. 51.
    Foy Y, Li J, Kirsner R, Eaglstein W. Analysis of fibroblast defects in extracellular matrix. J Am Acad Dermatol. 2004;50(3):P168.Google Scholar
  52. 52.
    Jhamb S, Vangaveti VN, Malabu UH. Genetic and molecular basis of diabetic foot ulcers: a clinical review. J Tissue Viability. 2016;25(4):229–36.CrossRefGoogle Scholar
  53. 53.
    Lai JY, Borson ND, Strausbauch MA, Pittelkow MR. Mitosis increases levels of secretory leukocyte protease inhibitor in keratinocytes. Biochem Biophys Res Commun. 2004;316:407–10.  https://doi.org/10.1016/j.bbrc.2004.02.065.CrossRefGoogle Scholar
  54. 54.
    Ching YH, Sutton TL, Pierpont YN, Robson MC, Payne WG. The use of growth factors and other humoral agents to accelerate and enhance burn wound healing. Eplasty. 2011;11.Google Scholar
  55. 55.
    Larouche J, Sheoran S, Maruyama K, Martino MM. Immune regulation of skin wound healing: mechanisms and novel therapeutic targets. Adv Wound Care. 2018;7:209–31.  https://doi.org/10.1089/wound.2017.0761.CrossRefGoogle Scholar
  56. 56.
    Bakker AD, Schrooten J, Van Cleynenbreugel T, Vanlauwe J, Luyten J, Schepers E, Dubruel P, Schacht E, Lammens J, Luyten FP. Quantitative screening of engineered implants in a long bone defect model in rabbits. Tissue Eng Part C: Methods. 2008;14(3):251–60.  https://doi.org/10.1089/ten.tec.2008.0022.
  57. 57.
    Pauli A, Valen E, Schier AF. Identifying (non-) coding RNAs and small peptides. Challenges and opportunities. Bioessays. 2015;37:103–12.  https://doi.org/10.1002/bies.201400103.CrossRefGoogle Scholar
  58. 58.
    Margolis DJ, Hampton M, Hoffstad O. NOS1AP genetic variation is associated with impaired healing of diabetic foot ulcers and diminished response to healing of circulating stem/progenitor cells. Wound Repair Regen. 2017;25:733–6.CrossRefGoogle Scholar
  59. 59.
    Viswanathan V, Dhamodharan U, Srinivasan V, Rajaram R, Aravindhan V. Single nucleotide polymorphisms in cytokine/chemokine genes are associated with severe infection, ulcer grade and amputation in diabetic foot ulcer. Int J Biol Macromol. 2018;118:1995–2000.CrossRefGoogle Scholar
  60. 60.
    Lindley LE, Stojadinovic O, Pastar I, Tomic-Canic M. Biology and biomarkers for wound healing. Plast Reconstr Surg. 2016;138:18S–28S.  https://doi.org/10.1097/prs.0000000000002682.CrossRefGoogle Scholar
  61. 61.
    Stojadinovic O, Brem H, Vouthounis C. Molecular pathogenesis of chronic wounds: the role of β-catenin and c-myc in the inhibition of epithelialization and wound healing. Am J Pathol. 2005;167:59–69.  https://doi.org/10.1016/s0002-9440(10)62953-7.CrossRefGoogle Scholar
  62. 62.
    Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Investig. 2007;117(5):1219–22.Google Scholar
  63. 63.
    Johnson T, Gómez B, McIntyre M, Dubick M, Christy R, Nicholson S, Burmeister D. The cutaneous microbiome and wounds: New molecular targets to promote wound healing. Int J Mol Sci. 2018;19(9):2699.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Medical Microbiology, Faculty of MedicineUniversity of TabukTabukKingdom of Saudi Arabia
  2. 2.Rajiv Gandhi Centre for Diabetes and Endocrinology, Faculty of Medicine, J.N. Medical CollegeAligarh Muslim UniversityAligarhIndia

Personalised recommendations